Cerenome (PSTV) Asset Utilization Ratio (2011 - 2026)
Plus Therapeutics (PSTV) posted quarterly Asset Utilization Ratio of 0.29 for Q1 2026, down 48.67% year-over-year from 0.56 in Q1 2025, and down 4.01% quarter-over-quarter from 0.3 in Q4 2025.
Cerenome (PSTV) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Asset Utilization Ratio for 14 consecutive years, with 0.29 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 48.67% year-over-year to 0.29; the TTM figure through Mar 2026 stood at 0.29 (down 48.67% YoY), while the FY2025 annual figure was 0.45, down 29.74% from the prior year.
- Asset Utilization Ratio eased to 0.29 in Q1 2026 per PSTV's latest filing, from 0.3 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.86 in Q4 2024 and bottomed at 0.01 in Q4 2022.
- Historically, Asset Utilization Ratio has averaged 0.35 across 5 years, with a median of 0.3 in 2025.
- On a YoY basis, Asset Utilization Ratio climbed as much as 4615.95% in 2023 and fell as far as 72.38% in 2023.
- Plus Therapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then surged by 4615.95% to 0.4 in 2023, then surged by 113.09% to 0.86 in 2024, then slumped by 65.19% to 0.3 in 2025, then declined by 4.01% to 0.29 in 2026.
- Business Quant data shows PSTV's Asset Utilization Ratio at 0.29 in Q1 2026, 0.3 in Q4 2025, and 0.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.13 |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.29 |
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.56 |
| Dec 31, 2024 | 0.86 |
| Sep 30, 2024 | 0.63 |
| Jun 30, 2024 | 0.65 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.40 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 0.17 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.13 |
| Mar 31, 2019 | 0.15 |
| Dec 31, 2018 | 0.15 |
| Sep 30, 2018 | 0.12 |